China Resources Pharmaceutical plans HK IPO worth at least $1 bln
Saturday, February 06, 2016
China Resources Pharmaceutical Group, a unit of state-owned conglomerate China Resources (Holdings) Co Ltd., plans a Hong Kong initial public offering of at least $1 billion, IFR reported on Friday, citing people close to the deal.
CR Pharma, as the company is called, has sent a request for proposals to banks seeking a role in the deal, with a deadline of Feb. 16 for banks to respond, added IFR, a Thomson Reuters publication.
CR Pharma didn't immediately reply to a Reuters request for comment on the listing plans.
reuters.com
